Correlation Between Edwards Lifesciences and CONMED

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edwards Lifesciences and CONMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edwards Lifesciences and CONMED into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edwards Lifesciences Corp and CONMED, you can compare the effects of market volatilities on Edwards Lifesciences and CONMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edwards Lifesciences with a short position of CONMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edwards Lifesciences and CONMED.

Diversification Opportunities for Edwards Lifesciences and CONMED

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Edwards and CONMED is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Edwards Lifesciences Corp and CONMED in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CONMED and Edwards Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edwards Lifesciences Corp are associated (or correlated) with CONMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CONMED has no effect on the direction of Edwards Lifesciences i.e., Edwards Lifesciences and CONMED go up and down completely randomly.

Pair Corralation between Edwards Lifesciences and CONMED

Allowing for the 90-day total investment horizon Edwards Lifesciences is expected to generate 3.46 times less return on investment than CONMED. But when comparing it to its historical volatility, Edwards Lifesciences Corp is 2.12 times less risky than CONMED. It trades about 0.16 of its potential returns per unit of risk. CONMED is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  6,376  in CONMED on August 28, 2024 and sell it today you would earn a total of  1,013  from holding CONMED or generate 15.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Edwards Lifesciences Corp  vs.  CONMED

 Performance 
       Timeline  
Edwards Lifesciences Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Edwards Lifesciences is not utilizing all of its potentials. The newest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
CONMED 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CONMED are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, CONMED may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Edwards Lifesciences and CONMED Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edwards Lifesciences and CONMED

The main advantage of trading using opposite Edwards Lifesciences and CONMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edwards Lifesciences position performs unexpectedly, CONMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CONMED will offset losses from the drop in CONMED's long position.
The idea behind Edwards Lifesciences Corp and CONMED pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Valuation
Check real value of public entities based on technical and fundamental data